TokioTHERA Holdings, Inc., leading comprehensive support of pharmaceuticals from a new perspective

Newly developed drug vaccine

Discovery of highly safe vaccines that prevent the onset of multiple myeloma, stop progression, and minimize the probability of recurrence

---

Clinical trial department

Joint research with Dr. Hiroshi Yasui, Department of Hematological/Oncology, Research Hospital, The Institute of Medical Science, University of Tokyo (4-6-1 Shirokanedai, Minato-ku, Tokyo)

---

Multiple myeloma

Currently, there are certain treatment guidelines for treatment of multiple myeloma, but regrettably, multiple myeloma still uncured. Novel immunotherapy is strongly needed to cure multiple myeloma.
This time, focusing on that point, we are examining clinical trials for treatment of multiple myeloma.
⇒　enlarging the photo　　　　Provided 　by Dr. Hiroshi Yasui

---

Pathological features of multiple myeloma

There are increase in malignant plasma cells so called “myeloma cells” in the bone marrow.
t is basophilic cell which has the eccentric axle nucleus and the Golgi apparatus looking shining white.
⇒　enlarging the photo　　　Provided 　by Dr. Hiroshi Yasui

---